216 related articles for article (PubMed ID: 31004666)
1. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis.
Li Y; Pu S; Liu Q; Li R; Zhang J; Wu T; Chen L; Li H; Yang X; Zou M; Xiao J; Xie W; He J
J Control Release; 2019 Jun; 303():77-90. PubMed ID: 31004666
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of the binding of cyclic RGDyK to hepatic stellate cells.
Huang XW; Wang JY; Li F; Song ZJ; Xie C; Lu WY
Biochem Pharmacol; 2010 Jul; 80(1):136-43. PubMed ID: 20303335
[TBL] [Abstract][Full Text] [Related]
3. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
[TBL] [Abstract][Full Text] [Related]
4. Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice.
Li F; Yan H; Wang J; Li C; Wu J; Wu S; Rao S; Gao X; Jin Q
Biomaterials; 2016 Sep; 102():162-74. PubMed ID: 27341269
[TBL] [Abstract][Full Text] [Related]
5. [
Shao T; Chen Z; Belov V; Wang X; Rwema SH; Kumar V; Fu H; Deng X; Rong J; Yu Q; Lang L; Lin W; Josephson L; Samir AE; Chen X; Chung RT; Liang SH
J Hepatol; 2020 Jul; 73(1):161-169. PubMed ID: 32145257
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.
Wan L; Xia T; Du Y; Liu J; Xie Y; Zhang Y; Guan F; Wu J; Wang X; Shi C
FASEB J; 2019 Jul; 33(7):8530-8542. PubMed ID: 30970216
[TBL] [Abstract][Full Text] [Related]
7. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
[TBL] [Abstract][Full Text] [Related]
8. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
Du SL; Pan H; Lu WY; Wang J; Wu J; Wang JY
J Pharmacol Exp Ther; 2007 Aug; 322(2):560-8. PubMed ID: 17510318
[TBL] [Abstract][Full Text] [Related]
9. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
Li Q; Yan Z; Li F; Lu W; Wang J; Guo C
Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
11. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.
Duong HT; Dong Z; Su L; Boyer C; George J; Davis TP; Wang J
Small; 2015 May; 11(19):2291-304. PubMed ID: 25641921
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Patsenker E; Popov Y; Stickel F; Schneider V; Ledermann M; Sägesser H; Niedobitek G; Goodman SL; Schuppan D
Hepatology; 2009 Nov; 50(5):1501-11. PubMed ID: 19725105
[TBL] [Abstract][Full Text] [Related]
13. Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways.
Wang J; Ding Y; Zhou W
Int J Pharm; 2020 Jan; 574():118940. PubMed ID: 31830578
[TBL] [Abstract][Full Text] [Related]
14. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells secreting WFA
Bekki Y; Yoshizumi T; Shimoda S; Itoh S; Harimoto N; Ikegami T; Kuno A; Narimatsu H; Shirabe K; Maehara Y
J Gastroenterol Hepatol; 2017 Jul; 32(7):1387-1393. PubMed ID: 28008658
[TBL] [Abstract][Full Text] [Related]
16. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study.
Zhang X; Xin J; Shi Y; Xu W; Yu S; Yang Z; Liu C; Cao L; Guo Q
Nucl Med Biol; 2015 Mar; 42(3):250-5. PubMed ID: 25530210
[TBL] [Abstract][Full Text] [Related]
17. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro.
Wang J; Wu Z; Xia M; Salas SS; Ospina JA; Buist-Homan M; Harmsen MC; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167020. PubMed ID: 38244390
[TBL] [Abstract][Full Text] [Related]
19. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis.
Kong M; Hong W; Shao Y; Lv F; Fan Z; Li P; Xu Y; Guo J
J Mol Med (Berl); 2019 Nov; 97(11):1521-1533. PubMed ID: 31435710
[TBL] [Abstract][Full Text] [Related]
20. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
